Heparins: For unfractionated heparins, certain studies have demonstrated in
creased hemorrhage rates correlated with age and with renal function. Subcu
taneous injections every 12 hours are as effective and less uncomfortable f
or the patient than continuous intravenous infusions. Low-molecular-weight
heparins are currently contraindicated for curative treatment and their use
is not recommended for prevention when the creatinine clearance is below 3
0 ml/min.
Other anticoagulants: The dosage of sodium daparanoid should be adapted to
the renal function with regular surveillance of anti Xa activity. With hiru
din, there is a risk of product accumulation in case of renal failure. For
oral anticoagulants the relationship between old age and the frequency of h
emorrhagic complications is still a subject of debate.
Oral anticoagulants: The starting dosage should be reduced to one-half or o
ne-quarter of the usual dose. The INR should be measured regularly, particu
larly since elderly subjects are highly susceptible to wide variations in I
NR irrespective of the cause. It is also advisable to carefully determine a
ppropriate situations when oral coagulants should be used.